Company
United StatesNovartis Gene Therapies Inc., Durham, NC – FDA Inspections
Inspection records and compliance data for Novartis Gene Therapies Inc. in Durham, North Carolina. 1 FDA inspection on record, last inspected January 26, 2024.
Company Profile
This profile covers Novartis Gene Therapies Inc. based in Durham, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected January 26, 2024.
Most cited issue areas
- Extent of discrepancy, failure investigations1 inspection
- When to report1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 26, 2024 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1228634 |
FDA documents
Form 483s (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novartis Gene Therapies Inc.
FEI Number
3015404862
Address
2512 S Tricenter Blvd, Durham, North Carolina 27713, United States
Country
United States
ID: 23cc49c0-8794-437d-a2c2-4197479c5fb3